{"product_id":"c-raf-antibody-sc-f0353","title":"Phospho-c-Raf (Ser338) Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eThe Raf family of kinases, comprising A-Raf, B-Raf, and c-Raf (Raf-1), are key serine\/threonine protein kinases that act as downstream effectors of Ras, playing essential roles in regulating cell proliferation, survival, and tumorigenesis. c-Raf contains a core kinase domain responsible for phosphorylating downstream targets like MEK, and multiple phosphorylation sites that regulate its activity. Phosphorylation at Ser338 is crucial for c-Raf activation; it can occur in response to mitogenic signals or independently of Ras via Cdc42\/Rac\/Pak activation following microtubule depolymerization. Depending on the literature source, C-RAF may also be discussed as Phospho-c-Raf (Ser338).\u003c\/p\u003e\u003cp\u003eReported cellular context includes cell membrane, cytoplasm, membrane, and mitochondrion, which can matter when signal is compared across treatments or changing cell states. Following C-RAF across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eC-RAF is commonly interpreted in the context of cancer and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, cytoplasm, and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cell membrane, cytoplasm, and membrane across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003cli\u003edifferences between total target abundance and site-specific regulation when modified forms are compared\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for C-RAF. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in C-RAF reflect biology rather than handling. When interpreting C-RAF, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep C-RAF trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577445687641,"sku":"F0353-20UL","price":159.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577445720409,"sku":"F0353-100UL","price":389.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577445753177,"sku":"F0353-2X100UL","price":579.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F0353-wb.gif?v=1773598365","url":"https:\/\/absource.de\/products\/c-raf-antibody-sc-f0353","provider":"Absource Diagnostics","version":"1.0","type":"link"}